Liver Injury Clinical Trials

6 recruiting

Liver Injury Trials at a Glance

8 actively recruiting trials for liver injury are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Phase 2 with 1 trial, with the heaviest enrollment activity in Hangzhou, Berlin, and Cleveland. Lead sponsors running liver injury studies include Protara Therapeutics, Qin Zhang, and First Affiliated Hospital of Zhejiang University.

Browse liver injury trials by phase

Treatments under study

About Liver Injury Clinical Trials

Looking for clinical trials for Liver Injury? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Liver Injury trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Liver Injury clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 2Phase 3

Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support

Liver InjuryCholine Deficiency
Protara Therapeutics129 enrolled14 locationsNCT06910943
Recruiting

Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients

Liver InjuryPelvic FractureAortic Dissection+11 more
University of California, Los Angeles12,000 enrolled1 locationNCT04937868
Recruiting

Multicenter Clinical Study on Noninvasive Assessment of Hepatic Steatosis and Fibrosis Using Visual Transient Elastography

Chronic Liver InjuryMindray Hepatus 9 Ultrasound Diagnostic System
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine225 enrolled1 locationNCT07128108
Recruiting

A Prospective Study of ¹⁸F-DFA PET Imaging for the Assessment of Liver Injury

Liver Injury
First Affiliated Hospital of Zhejiang University45 enrolled1 locationNCT07050550
Recruiting

Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis

Cancer PatientsLiver InjurySecondary to Immune Checkpoint Inhibitors
University Hospital, Montpellier250 enrolled1 locationNCT06864481
Recruiting

Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-control Study

ChinaPharmacogeneticsAcetaminophen+1 more
The First Affiliated Hospital with Nanjing Medical University339 enrolled1 locationNCT04964310
Recruiting

A Clinical Study on the Analysis of Risk Factors for the Occurrence of PD-1/PD-L1 Inhibitor-associated Liver Injury in Lung Cancer Patients

Immune Checkpoint InhibitorsLiver Injury
Zhejiang University2,000 enrolled1 locationNCT06402981
Recruiting

Liver Ischemia-reperfusion Injury and Clinical Data Analysis

Liver Injury
Qin Zhang270 enrolled1 locationNCT06080308